NUK - logo
E-resources
Full text
Peer reviewed Open access
  • Successful Management of Cr...
    Muto, Masahiro; Sasaki, Yu; Kano, Toshiki; Fukao, Yusuke; Hosoya, Reina; Nomura, Tomohisa; Sugita, Manabu; Io, Hiroaki; Suzuki, Yusuke

    Internal Medicine, 11/2023, Volume: 62, Issue: 21
    Journal Article

    A 44-year-old man with coronavirus disease 2019 (COVID-19) and nephrotic syndrome relapse was admitted to our intensive-care unit for respiratory failure. Despite receiving mechanical ventilation and immunomodulators, the patient experienced refractory hypoxemia, necessitating venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy. Due to a worsening renal function, continuous hemodiafiltration was initiated. After 11 days, his respiratory status gradually improved, and VV-ECMO was withdrawn. The kidney function and proteinuria improved, and hemodialysis was subsequently discontinued. The patient was discharged 64 days after admission. This case highlights the potential benefit of early ECMO application in dramatically promoting recovery in severe COVID-19 cases.